Category Archives: FDA Policy

Fewer Letters, Fewer Warning Letters

It may seem that I write a lot about the letters that FDA puts out regarding industry promotion and communication, but that is exactly what the nature of this blog is about. Other things can be interesting, particularly policy developments, … Continue reading

Posted in FDA Policy, Warning Letters | Comments Off

Now What? Post-Election and FDA

We are finally post-election.  The sense of relief that one can watch or listen to broadcast television or radio without seeing campaign ads is still being felt nationwide.  Facebook sidebars are free of political jabber and de-friending over politics has … Continue reading

Posted in FDA Policy, Legislation, Politics | Comments Off

FDLI Conference on Advertisting and Promotion

The Food and Drug Law Institute held its annual conference on Advertising and Promotion for the Pharmaceutical, Medical Device, Biologic and Veterinary Medicine Industries in Washington, D.C. on October 1 and 2.  I was able to attend sporadically and participated … Continue reading

Posted in FDA Policy, Medical Devices, New and Social Media | 1 Comment

Interesting Bits from GAO Report on FDA Performance Goals

On April 30, 2012 the GAO released a report entitled “FDA Has Met Most Performance Goals for Reviewing Applications” where the title pretty much sums it up.  FDA has been doing well in terms of meeting goals related to the … Continue reading

Posted in FDA Policy | Comments Off

FDA to Examine Inhaled Caffeine

The Associated Press reported this weekend that FDA officials have expressed intent to investigate the marketing of an inhaled caffeine product.   The product, called AeroShot, is described as a fine powder that is in a lip-stick type of tube … Continue reading

Posted in FDA Policy, Vitamins and Supplements | Comments Off